ENTRY       D05716                      Drug
NAME        Repifermin (USAN/INN)
FORMULA     C723H1131N209O204S5
EXACT_MASS  16165.3155
MOL_WEIGHT  16175.3191
SEQUENCE    SYNHLQGDVR WRKLFSFTKY FLKIEKNGKV SGTKKENCPY SILEITSVEI GVVAVKAINS
            NYYLAMNKKG KLYGSKEFNN DCKLKERIEE NGYNTYASFN WQHNGRQMYV ALNGKGAPRR
            GQKTRRKNTS AHFLPMVVHS
  TYPE      Peptide
EFFICACY    Anti-inflammatory, Wound healing
COMMENT     Treatment of mucositis and to promote wound healing
            33-172-Keratinocyte growth factor 2 [HSA:2255] [KO:K04358]
TARGET      FGFR [HSA:2260 2263 2261 2264] [KO:K04362 K05093 K05094 K05095]
  PATHWAY   hsa04520(2260)  Adherens junction
            hsa04550(2260+2261+2263+2264)  Signaling pathways regulating pluripotency of stem cells
            hsa04810(2260+2261+2263+2264)  Regulation of actin cytoskeleton
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               FGFR family
                FGFR
                 D05716  Repifermin (USAN/INN)
DBLINKS     CAS: 219527-63-6
            PubChem: 47207377
///
